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Abstract
Background: Health care workers in the addiction field have long emphasised the importance of a patient’s
motivation on the outcome of treatments for substance use disorders (SUDs). Many patients entering treatment are
not yet ready to make the changes required for recovery and are often unprepared or sometimes unwilling to
modify their behaviour. The present study compared stages of readiness to change and readiness to seek help
among patients with SUDs involuntarily and voluntarily admitted to treatment to investigate whether changes in
the stages of readiness at admission predict drug control outcomes at follow-up.
Methods: This prospective study included 65 involuntarily and 137 voluntarily admitted patients treated in three
addiction centres in Southern Norway. Patients were evaluated using the Europ-ASI, Readiness to Change
Questionnaire (RTCQ), and Treatment Readiness Tool (TReaT).
Results: The involuntarily admitted patients had significantly lower levels of motivation to change than the
voluntarily admitted patients at the time of admission (39% vs. 59%). The majority of both involuntarily and
voluntarily admitted patients were in the highest stage (preparation) for readiness to seek help at admission and
continued to be in this stage at discharge. The stage of readiness to change at admission did not predict
abstinence at follow-up. The only significant predictor of ongoing drug use at 6 months was SUD severity at
baseline.
Conclusions: The majority of involuntarily admitted patients scored high on motivation to seek help. Their
motivation was stable at a fairly high level during their stay, and even improved in some patients. Thus, they were
approaching the motivation stage similar to the voluntarily admitted patients at the end of hospitalization.
Therapists should focus on both motivating patients in treatment and adapting the treatment according to SUD
severity.
Trial registration: ClinicalTrials.gov, NCT00970372. Registered 1 September 2008, https://clinicaltrials.gov/ct2/show/
NCT00970372. The trial was registered before the first participant was enrolled. The fist participant was enrolled
September 02, 2009.
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Background
Health care workers in the addiction field have long
emphasised the importance of patient motivation to the
outcome of treatment for substance use disorders
(SUDs). Many patients entering treatment are not yet
ready to make the changes required for recovery and are
often unprepared or sometimes unwilling to modify their
behaviour [1]. If lack of motivation is a common
phenomenon in treatment, this may impact treatment
outcomes [2, 3].
The most prevalent and widely used model to oper-
ationalise patient motivation to change in substance use
treatment is the Transtheoretical Model [1]. The work
of Prochaska and DiClemente on “stages of change” has
become the conceptual and theoretical foundation for
much of the work on motivation in the substance use
field and in behavioural health in general. The model de-
picts categories in which patients tend to fall into when
making significant changes in their lives, such as enter-
ing treatment. The model can be viewed as a continuum
along which an individual may move toward long-lasting
or permanent change. This model posits three stages
that represent progressively greater commitment to
change (Fig. 1) [4].
Precontemplation represents a stage in which there is
little or no consideration of changing the current pattern
of behaviour in the foreseeable future. Precontemplation
is characterised by a lack of intent to change. The prob-
lem is not yet recognised as troublesome and/or may be
seen as having more benefits than drawbacks for the
person. Contemplation represents a stage in which the
patients examine the current pattern of behaviour and
potential for change in a risk-reward analysis. Contem-
plation is characterised by the individual thinking about
the possibility of change, seeking and evaluating infor-
mation, but not yet being fully prepared to change.
Action represents the stage in which the patient imple-
ments the plan and takes active steps to change their
current behaviour pattern and to begin creating a new
behaviour pattern, such as entering treatment. Action is
characterised by modification of the problem behaviour
(e.g. protracted periods of abstinence, increased activity
in therapy sessions, voluntary attendance of self-help
meetings) and the development of new skill sets to pre-
vent returning to the problem behaviour (e.g., help-
seeking, use of Narcotics Anonymous or Alcoholics
Anonymous sponsors, honestly talking about cravings).
To respond to harmful substance use, most countries
provide some form of compulsory commitment to treat-
ment [5, 6]. This is often motivated by the intent to pro-
tect an otherwise legally capable individual in a self-
destructive and vulnerable situation due to substance
use [5]. It is a controversial treatment option that should
only be implemented after voluntary care has had unsuc-
cessful results [5–8]. Norway also has a public health act
that permits involuntary interventions for adult patients
with SUDs. The act covers an option for retention of up
to 3months when voluntary efforts are insufficient, and
the health of the patient is at serious risk because of ex-
tensive and prolonged substance use. In the acute phase
of compulsory treatment, the main goal of retention is
to provide life-saving treatment for the involuntarily ad-
mitted (IA) SUD patients. Over the longer term, the aim
of treatment is to motivate patients to enter voluntary
treatment and engage in change processes towards long-
term recovery [9].
Legally coerced treatment remains controversial and
poses a variety of challenges for health care workers
[10]. This controversy often focuses on a debate about
the effectiveness of coerced treatment [11, 12]. Concerns
about the efficacy of legally coerced treatment for SUD
stems from beliefs that coercion interferes with the abil-
ity to establish and maintain a therapeutic relationship
that enables participants to benefit from treatment.
Another concern is based on the notion that, to fully
benefit from treatment, patients must be motivated to
participate in treatment and change behaviour, and that
the use of coercion disregards the importance of internal
motivation in recovery. Compulsory commitment is the
most consistent type of coercion, and involuntarily
admitted patients may experience a type of “imprison-
ment”; there is a question of whether such an interven-
tion is able to lead patients to more self-motivated
actions towards recovery. Typically, it is considered to
Fig. 1 Modified Transtheoretical (Stages of Change) Model based on
the theory that individuals follow a circular rather than linear path as
they flow through a series of stages to modify behaviour (Modified
from the work of Prochaska and DiClemente)
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be crucially important that the treatment manages to
change the patient’s motivation. Little research has ex-
amined the stages of motivation and compulsory com-
mitment to treatment among patients with SUDs. The
few studies have had mixed outcomes [2, 12–14], and
the topic needs to be explored further.
The purpose of this study was to compare the stages
of readiness to change (motivation) between SUD pa-
tients who entered treatment voluntarily and those who
entered treatment involuntarily, and whether the stages
of patient readiness to seek help changed during the
treatment period. In addition, the patients´ experience of
being involuntarily admitted to the hospital and factors
associated with the ability to control drug use at 6
months of follow-up were investigated, with a focus on
the patient’s readiness to change.
Methods
Study subjects
Consecutive patients were admitted to specialized units
that offer treatment for patients with primary SUD often
combined with mental disorders [15]. Patients recruited
from one of three publicly funded treatment centres in
the south-eastern part of Norway during the years 2009
to 2011 were eligible for inclusion in the study. The pa-
tients mainly came from urban and suburban areas. The
IA patients were recruited from one of the centres in
Kristiansand, Tønsberg, and Oslo that have four, four,
and three beds for IA patients, respectively. All voluntar-
ily admitted (VA) patients were recruited from the same
ward of the Kristiansand centre.
The criteria for inclusion were: substance abuse or de-
pendence in accordance with the International Classifi-
cation of Diseases and Related Health Problems, 10th
Revision (ICD-10) [16], age ≥ 18 years, understanding/
speaking the Norwegian language, and at least 3 weeks
of admission. Patients with mental retardation and/or
not able to understand the questionnaires were ex-
cluded. Pregnant SUD patients were treated in separate
wards and were not included in this study.
The study was approved by The Regional Committee
for Research Ethics in Norway (REK 08/206d, 2008/2900,
09/2413) and by the Privacy Issues Unit, Norwegian Social
Science Data Services (NSD no. 18782). Written informed
consent was obtained from all study participants. The par-
ticipants received no financial compensation except NOK
200 (approx. USD 23) to cover travel expenses at follow-
up 6months after discharge.
Measurements
The three wards were organised similarly. All wards
were multidisciplinary (psychiatrists, psychologists, social
workers, occupational therapists, specialised nurses, and
other trained staff) and had specialised units that offered
treatment for patients with primary SUD, but often in-
cluded mental disorders. All units treated both genders,
but the majority of the patients were males. The patients
could use communal areas, but the exterior doors were
locked; however, most of the patients were allowed to
leave the ward if accompanied by a staff member. Many
patients received visits from friends and family. The pa-
tients had to give urine samples for drug-screenings both
as routine procedure and by suspicion. Treatment included
assessment of somatic and mental health, with diagnoses
based on a structured interview and examination in accord-
ance with the ICD-10, pharmacotherapy, cognitive milieu
therapy, and individual motivation enhancement.
Before inclusion in the study, patients in both the IA
and VA groups were detoxified, which was verified by
negative urine tests for alcohol, opioids, central
stimulants (amphetamines, methamphetamines, and co-
caine), benzodiazepines, and cannabis, or when a mini-
mum of 14 days were spent in detoxification to establish
baseline values that were not influenced by withdrawal
symptoms.
Sociodemographic variables were measured using the
European Addiction Severity Index, a personal struc-
tured interview designed for both clinical and research
purposes (Table 1). This index includes seven areas:
medical status, employment and support status, drug and
alcohol use, legal status, family history, family and social
relationships, and psychiatric status [17]. In this study, we
used the variables medical status, employment and
support status, and drug and alcohol use. A Norwegian
version of the European Addiction Severity Index-based
interviews were performed by trained and certified staff.
Injecting illicit drugs during the 6months before
Table 1 Instruments used in the study at admission, discharge and 6 months follow-up
Admission Discharge 6 months follow-up
ICD-10a Clinical interview/observation
European Addiction Severity Index Clinical interview/observation Clinical interview/observation
Readiness to Change Questionnaire Questionnaire
Treatment Readiness Tool Questionnaire Questionnaire
Follow up interview Clinical interview
aICD-10: International Classification of Diseases and Related Health Problems, 10th Revision
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admission and lifetime prevalence of overdoses were used
as indicators of SUD severity.
Motivation is defined as the process that initiates, guides,
and maintain goal-oriented behaviours, and is what causes
one to act. We investigated the performance of two motiv-
ation measures that separately assess readiness to change
(Readiness to Change Questionnaire; RTCQ) and readiness
to seek help (Treatment Readiness Tool; TReaT). The
RCTQ was originally developed for alcohol use and vali-
dated by Heather and Rollnick in 1993 [3]. It was modified
by Burke and Gregoire to measure readiness to change for
either alcohol or substance use [2]. In this study, an ap-
proved Norwegian forward-back translation of the Burke
and Gregoire version was used. The validity of the ques-
tionnaire was verified by Rollnick et al. [4].
The patient’s readiness to change their stage of motiv-
ation was assessed at the onset of treatment. The RCTQ
scale discriminates between three stages of motivation to
change based on the Transtheoretical Model of behaviour.
The RTCQ is a three-dimensional self-administered ques-
tionnaire assessing each of the stages with four item state-
ments regarding the patient’s beliefs about their current
alcohol and drug use [3]. The five-point scale ranges from
strongly disagree (− 2) to strongly agree (+ 2). According to
guidelines, if one of the four items on a scale is missing, the
subject’s score for that scale [18] should be pro-rated (i.e.,
multiplied by 1.33). If two or more items are missing, the
score cannot be calculated. In this case, the Stage of Change
Designation will be invalid. Three patients were missing
one of the four items and were prorated. One patient had
two missing items and his answers were removed from the
analysis. A negative score reflected overall disagreement
with the items measuring the stage of change, whereas a
positive score represented overall agreement. The highest
score among the subscales represented the State of Change
Designation. If two scale scores were equal, then the scale
further along the continuum of change (precontemplation,
contemplation, action) represented the subject’s Stage of
Change Designation. We assigned patients to one stage
based on their highest score.
Treatment readiness was measured at admission and
discharge to treatment by the TReaT, which is based on
the same theoretical model as the RCTQ. The TReaT
may have advantages in predicting treatment compli-
ance, and processes an outcome relative to the measure
of general behaviour change readiness [19]. The TReaT
is a 12-item self-report questionnaire referring to stages
of formal help-seeking readiness: precontemplation, con-
templation, and preparation. The item response scale is
dichotomous (true/not true). A Norwegian translation
was discussed and reviewed by recognised researchers in
the assessment of SUDs. Translated items were then
reviewed by the original authors of the assessment. Only
complete questionnaires were included in the analysis.
Six months after discharge, we interviewed the IA pa-
tients. The patients were asked about their experience of
being involuntarily admitted to the hospital. We used an
interview guide with five questions: 1) Why were you in-
voluntarily admitted to hospital? 2) Why did you not
want treatment for your substance use prior to hospital
admission? 3) What do you think afterwards about coer-
cion being used? 4) What were your experiences from
the actual involuntary admission? 5) What could have
been done differently?
Statistical analysis
Data were described by proportions (%), by median,
quartiles (Q1, Q3) and range, or by mean and standard
deviation (SD) when appropriate. The 95 percentage
confidence interval (CI) for the difference in observed
proportions between independent groups was calculated
according to Wilson [20]. In the case of significant evi-
dence of a difference, the test of differences in propor-
tions corrected for continuity was performed [21]. The
distribution of patient motivations on the three ordered
levels according to the RTCQ assessed in the IA and VA
patients were described by the median. The Wilcoxon-
Mann-Whitney test of possible differences in motivation
levels between the two independent groups was adjusted
for tied observations [22]. The proportions of patients
who changed their stages of motivation according to the
TReaT and the difference in paired proportions with
increased and decreased stages of motivation were calcu-
lated. The 95% CI for the difference in paired propor-
tions estimates the expected change in motivation in a
representative population [21].
A multiple linear regression model was used for mod-
elling the dependence of the proportion of days abstin-
ent the 30 days prior to follow-up on the variables SUD
severity (injecting drug as proxy), motivation, and hos-
pital admission type. The results are presented as β-
values with 95% CIs [21]. Analyses were performed using
SPSS 23.0 Software (SPSS Inc., Chicago, IL, USA).
The patients´ answers in the follow-up interview 6
months after discharge were analyzed using qualitative
content analysis based on Granheim and Lundmann [23]
and categorized into two categories. Numerical analyses
were performed using Microsoft Excel.
Results
A total of 103 consecutive IA patients were identified;
15 did not meet the inclusion criteria (12 because their
stay was too short and 3 because of insufficient mental
capacity) and 11 were not asked to participate because
of logistical issues. Of the 77 patients eligible for inclu-
sion, 12 refused to participate. Therefore, the rate of
consent to participate among IA patients was 84% (65
patients). We identified a total of 223 VA patients; 72
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were excluded (69 because their stay was too short and
3 because they lacked sufficient mental capacity). Of the
remaining 151 VA patients, 14 refused to participate.
Therefore, the rate of consent in the VA group was 91%
(137 patients). The baseline characteristics of the 202 pa-
tients included in this study are given in Table 2. The
different substances used were alcohol and illegal drugs
like heroin, other opiates, benzodiazepines and other
sedatives, amphetamines, cannabis, cocaine, inhalants,
and hallucinogens. The mental statuses were divided in
severe mental diagnoses (F20-F39), other mental diagno-
ses (F40-F99) and no mental diagnosis. A larger propor-
tion of patients in the IA group than the VA group
injected illicit drugs 6 months prior to admission to the
study (p = 0.01). There was also a difference in propor-
tion of patients that experienced overdoses during their
Table 2 Baseline sociodemographic variables and mental stress scores for involuntarily admitted or voluntarily admitted patients
Involuntary n/Voluntary n Involuntary Voluntary
Age, years
Median 65/137 24 28
Q1, Q3 65/137 21.0, 34.5 23.5, 36.0
Range 65/137 18.0–57.0 19.0–61.0
Female, n (%) 65/137 31 (48) 37 (27)
Substance useb, d
Alcohol 60/132 29 (48.3) 41 (31.1)
Heroin 61/134 21 (34.4) 18 (13.4)
Other opiates 60/130 11 (18.3) 25 (19.2)
Benzodiazepines, other sedatives 60/134 39 (65.0) 63 (47.0)
Amphetamines 62/135 35 (56.5) 67 (49.6)
Cannabis 61/133 32 (52.5) 71 (53.4)
Cocaine, inhalants, hallucinogens 60/132 12 (20.0) 18 (13.6)
Mental diagnosis
No mental diagnosis 65/137 26 (40.0) 35 (25.5)
Severe mental diagnoses (F20-F39) 65/137 14 (21.5) 38 (27.7)
Other mental diagnoses (F40-F99) 65/137 25 (38.5) 64 (46.7)
Education
Mean years in primary school and high school (SD) 59/130 10.5 (1.4) 10.6 (1.6)
Patients attending college and university, n (%) 59/130 4 (7) 14 (11)
Sources of financial supporta, b, n (%)
Employment 60/130 6 (10) 24 (19)
Public welfare benefits 62/135 59 (95) 115 (85)
Partner, family, or friends 60/130 17 (28) 37 (29)
Illegal activity 60/130 24 (40) 47 (36)
Living arrangementb, n (%)
With partner 59/130 8 (13) 11 (9)
Alone 59/130 31 (52) 62 (48)
With family 59/130 9 (15) 26 (20)
No stable arrangements 59/130 9 (15) 16 (12)
Controlled environment 59/130 2 (3) 15 (12)
Treated by a physician for somatic diseasesb, n (%) 60/130 24 (40) 32 (25)
Injecting illicit drugb, n (%) 61/134 43 (71) 62 (46)
Overdoses on drugsc, n (%) 59/130 41 (70) 63 (49)
Suicide attemptsc, n (%) 60/131 23 (38) 71 (54)
Q1, Q3: first, third quartile, SD: standard deviation. aSome patients had more than one source of financial support,
bLast 6 months before admission, cLifetime prevalence, dSome patients had more than one substance use
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lifetime (p = 0.02). In addition, a larger proportion of IA
patients than VA patients were treated by a physician
for somatic complaints 6 months prior to admission.
However, a greater proportion of VA patients than IA
patients attempted suicide at some point in their lives
(proxy severe mental health symptom burden).
Readiness to change
At admission, 39% of the IA group was in the stage of
action vs. 59% of the VA group (Fig. 2). Significantly
more VA patients than IA patients had a high score on
action (P = 0.025). The IA patients scored significantly
lower levels of motivation than the VA patients, with the
median levels being contemplation and action, respect-
ively (p = 0.008).
Change in stage of readiness to seek help
The majority of involuntarily admitted patients scored high
on motivation to seek help. Their motivation was stable at
a fairly high level during their stay, and even improved in
some patients. Four of the 45 IA patients changed to a
lower stage and 7 to higher stages of readiness to seek help
during treatment (Fig. 3a). The majority remained in the
highest stage (i.e., preparation) throughout the involuntary
treatment period. This means an estimate of 6.7 percentage
units for increased readiness to seek help among these pa-
tients (non-significant). Corresponding results for the VA
patients were 11 of the 108 patients changing to lower and
4 to higher stages of readiness to seek help. Thus, the in-
voluntarily admitted patients were approaching the motiv-
ation stage similar to the voluntarily admitted patients at
the end of hospitalization. None of the above findings rep-
resent significant changes in readiness to seek help.
In multiple linear regression analysis, only injecting
drug use reported at admission was a significant ex-
planatory variable for ongoing drug use at follow-up.
Age, gender, readiness for change, or admission formal-
ities were not significant explanatory variables (Table 3).
At follow-up 6months after discharge, we performed
new interviews with the IA patients to ask about their
experience of being involuntarily admitted to the hos-
pital. Of the 48 patients, 36 (75%) said that they ac-
knowledged, in retrospect, that they needed help, and
that they were happy that someone cared. Twelve (25%)
of the patients were negative to the involuntary admis-
sion and had negative experiences overall. Most of these
12 patients experienced their admission as humiliating,
especially when/if uniformed police were involved.
Discussion
The IA patients scored significantly lower levels of mo-
tivation to change on the RTCQ than the VA patients at
admission. However, many patients in both groups were
in the highest stage (preparation) of readiness to seek
help (TReaT) at admission and continued to be in this
stage at discharge. The only significant predictor of on-
going drug use at 6 months was SUD severity at baseline.
Stage of readiness to change at admission did not predict
abstinence at follow-up.
According to the Norwegian Public Health Act
(§10.2), legal coercion into treatment for adult patients
with SUDs can only occur when voluntary efforts are in-
sufficient, the patient rejects treatment, and the health of
the patient is at serious risk due to extensive, prolonged
substance use [9]. Looking at the law’s criteria for invol-
untary admission, IA patients are expected to be less
motivated for change. The highest stage (action stage)
Fig. 2 Percentage of patients admitted to the hospital based on stage of Readiness to Change
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represents the stage in which the patient implements the
plan and takes active steps to change their current be-
haviour pattern and to begin creating a new behaviour
pattern. Although a significant difference was found be-
tween the IA and VA groups, it was unexpected that so
many IA patients were in this action stage. The precon-
templation stage represents a stage in which there is lit-
tle or no consideration to change the current pattern of
behaviour in the foreseeable future. Precontemplation is
characterised by the lack of intent to change. Consider-
ing that the IA patients had previously refused treat-
ment, it is assumed that several of the IA patients would
be in the precontemplation stage, but relatively few IA
and VA patients were in fact in this stage. This could be
explained by ambivalence, resistance to treatment be-
cause of poor experience with prior treatment, or psy-
chological defence mechanisms, such as denial, trifling,
and projection [24].
The longer term aim of involuntary treatment is to
motivate the patients to subsequently enter voluntary
treatment programs and engage in change processes to-
wards long-term recovery [9]. Other studies have shown
that readiness to change and readiness to seek help are
not congruent [19, 25, 26]. At the time of admission,
two-thirds of the IA patients reported that they were
now motivated for a treatment they had rejected earlier.
An explanation may be ambivalence, as the patient may
have acknowledged that drugs are destroying his/her life,
but he/she could not leave behind the drug-taking be-
haviour. Ambivalence is often prominent in SUDs [27].
In the IA group, the readiness to seek help increased
during treatment, corresponding to the IA patients’ an-
swers at follow-up 6months after discharge when asked
about their experience of being involuntarily admitted to
the hospital. Thus, motivation is not static and may vary
with time. Patients can change from one moment to
another according to perceived environmental stimuli
and also from internal motivation. The Stages of Change
Model does not take into account the environment sur-
rounding the individual [28]. Outside forces can easily
affect the ability of people to change either by support-
ing continued use or by creating barriers to positive
behavioral change. SUD is perceived as a chronic pro-
gressive disorder requiring treatment over time. The
purpose of the Norwegian Public Health Act is for IA
patients to be detained for up to 3 months while trying
to improve their motivation for further voluntary treat-
ment. This study shows stability and a slight increase in
motivation for treatment during a stay, but there is still
potential for further work with motivational issues
during treatment. Clinical experience shows that it takes
time to change drug use behaviours. Swedish legislation
[29] permits withholding for up to 6 months. Thus,
Swedish institutions have a greater opportunity to facili-
tate improvements for motivation change with legal
coercion into treatment.
Fig. 3 Changes in Treatment Readiness Tool (TReaT) stage from admission to discharge from addiction treatment centres. a Involuntarily
admitted patients (n = 45). b Voluntarily admitted patients (n = 108). Unchanged stage: Yellow, changed to lower stage: Red, changed to higher
stage: Green
Table 3 Multiple regression analysis of the proportion of
abstinence days 30 days prior to follow-up
Characteristic Coefficient b P-value (95% CI)
Constant 72.5 0.001 (40.3 to 104.8)
Injected drug abusea −25.5 0.002 (−41.7 to −9.2)
Involuntary hospital admission −16.0 0.076 (−33.7 to 1.7)
Readiness for change (RCTQ) 14.0 0.083 (−1.9 to 29.9)
Age 0.2 0.696 (−0.7 to 1.0)
Gender −8.6 0.318 (−25.5 to 8.4)
aDuring the 6 months prior to admission
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We were interested in investigating whether stages on
the RTCQ before admission could predict the outcome
of drug control (proportion of abstinent days last 30
days) prior to follow-up 6months post-discharge. Based
on previously published results by Heather et al. [3], we
expected that a high stage of motivation to change (stage
of action) would predict a better outcome. Our expect-
ation failed. In the linear multiple regression analysis, we
found that severity of SUD (injecting drug use as re-
ported at admission) was the only significant explanatory
variable for ongoing drug use at follow-up.
Burke and Gregoire found that IA patients are more
likely than VA patients to report abstaining from alcohol
and other drugs in the 30 days before their follow-up
interviews. They were also more likely to demonstrate
reduced addiction severity at follow-up. Readiness to
change at admission exhibited no relationship with treat-
ment outcomes [14]. IA patients reported better out-
comes at the 6-month follow-up, even when taking into
account the differences in RTCQ stage and addiction se-
verity at admission [14]. Myers et al. found that the
Stages of Change, Readiness, and Treatment Eagerness
Scale (SOCRATES) predicted reduced substance use in a
randomised controlled trial of patients attending South
African emergency departments [30]. The only variable
associated with change in substance use involvement
from baseline to follow-up was baseline SOCRATES
score. Heather and colleagues found that the stage of
change was an accurate predictor of alcohol consump-
tion among heavy drinkers at the 6-month follow-up [3].
For a lasting change, new behaviours and new habits
must be incorporated, and that takes time (usually
months). Therefore, motivation itself is not enough to
make a change.
The outcomes of studies on motivation as a predictor
of change in drug use and drug control are mixed. Most
of the studies have been performed with VA patients.
However, our study, like Burke et al. [14], examined
both VA and IA patients.
Limitations
These findings should be considered in light of some
limitations. First, the sample size was relatively small,
limiting the power to identify group differences. The
sampling was limited to participants recruited from
three addiction centres in southern Norway. However,
we included a high number of IA patients relative to the
total annual number of IA patients nationally. This in-
creases the confidence in our findings, which may be
representative of the situation in other areas in Norway.
Second, the follow-up period was relatively short and
whether the effects of readiness to change on substance
use involvement could vary over time is unknown.
Therefore, we could not exclude the possibility that the
high percentage of individuals in the action stage found
in the involuntarily admitted patient group could be
explain by the fact that the RTCQ did not accurately
measure the stages of readiness to change. This could
also be a possible explanation for why the stage of readi-
ness to change at admission did not predict abstinence
at follow-up.
Clinical implications
Even if our study could not confirm that stage of readi-
ness to change prior to admission predicts drug control
6 months after discharge, using some of the motivation
scales will be beneficial in clinical work, regardless of
whether the therapy is Motivation Interview, Motivation
Enhancement, or others. Clinicians may use motivation
assessment for both clinical purposes and the prediction
of those who need extra monitoring due to increased
risk of premature attrition.
Furthermore, our study indicates that the IA patients
need treatment adapted primarily to the severity of the
disease. This means that the treatment should, to some
extent, disregard the stage of motivation upon admis-
sion. Good mapping and investigation provide the basis
for work with motivation, change, and prevention of
dropout during treatment. Therapeutic conversations,
activities, and meetings that contribute to positive expe-
riences can be important.
The majority of IA patients in our study were admitted
to the same department as VA patients, who had higher
average scores on the motivation scales. Joint compan-
ionship is thought to positively influence the effect be-
tween the two groups and may explain the stage of
motivation for treatment of IA patients approaching that
of the VA patients during their stay. Active user involve-
ment at the individual level also improves the ability of a
good therapist/patient relationship and helps achieve the
goal of the law regarding facilitation for further voluntary
treatment. Well-planned admissions, where the patient is
familiar with the decision about compulsory treatment
and has participated in the process, is thought to improve
the possibilities for motivating further treatment.
If the IA patient wishes further voluntary treatment,
this should be offered promptly. Information on the
place and selection of treatment, as well as repeated
attempts to involve the patient despite resistance, im-
proves the results by coercion [31]. Use of coercion also
seems to prevent disability and contribute to functional
improvement in quality of life for a longer period of
time [32].
Conclusions
We found a difference between the IA and VA patients
with both the RTCQ and TReaT. An unexpected finding
was that the majority of IA patients were motivated to
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seek help at treatment admission, and that their motiv-
ation was stable at a fairly high level during their stay,
and even improving for some of the patients. Thus, they
were approaching the motivation stage of the VA pa-
tients. Further studies with a larger sample size and
longer follow-up should be performed to confirm the re-
sults of this study.
In the future, it will be important for therapists to
focus on motivating patients for further treatment and
adapting the treatment to their SUD severity.
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